Ludwig-Maximilians-Universitat Munchen
🏢 View company profile →95Patents
87Active
95Granted
56Portfolio score
Filing activity: Jul 10, 2001 → Nov 1, 2023 · 24 expiring within 5 years
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8455435B2 | Remedies for ischemia | Human Necessities | 36 | Active |
| US9624274B2 | Mutated structural protein of a parvovirus | Chemistry; Metallurgy | 32 | Active |
| US7794388B2 | Method and apparatus for generating at least one section of a virtual 3D model of a body interior | Human Necessities | 28 | Active |
| US8431903B2 | Fast thermo-optical particle characterisation | Emerging Cross-Sectional Technologies | 24 | Active |
| US7223563B2 | Fibroblast growth factor (FGF23) nucleic acids | Chemistry; Metallurgy | 24 | Expired |
| US9784559B2 | Swept source OCT system and method with phase-locked detection | Physics | 19 | Active |
| US9318867B2 | Laser device with Kerr effect based mode-locking and operation thereof | Electricity | 18 | Active |
| US7314618B2 | Antibodies to fibroblast growth factor (FGF23) | Chemistry; Metallurgy | 17 | Expired |
| US8310230B2 | Method and device for sensing microwave magnetic field polarization components | Physics | 8 | Active |
| US9851303B2 | System and method for inducing and detecting multi-photon processes in a sample | Electricity | 6 | Active |
| US7384580B2 | Method of preparing organomagnesium compounds | Chemistry; Metallurgy | 5 | Expired |
| US7919673B2 | Transgenic pig with altered incretin function | Physics | 5 | Active |
| US8853650B2 | Fast thermo-optical particle characterisation | Emerging Cross-Sectional Technologies | 5 | Active |
| US8130802B2 | Tunable laser | Electricity | 5 | Active |
| US8134005B2 | Preparation and use of magnesium amides | Chemistry; Metallurgy | 4 | Active |
| US10101268B2 | Method and apparatus for measuring a spectral sample response | Physics | 4 | Active |
| US10633451B2 | Bispecific antibody molecules with antigen-transfected T-cells and their use in medicine | Emerging Cross-Sectional Technologies | 4 | Active |
| US10071966B2 | Drug for inhibiting aggregation of proteins involved in diseases linked to protein aggregation and/or neurodegenerative diseases | Physics | 3 | Active |
| US9521845B2 | Beta-lactones as antibacterial agents | Chemistry; Metallurgy | 3 | Active |
| US11104708B2 | Articles comprising a silk polypeptide for antigen delivery | Chemistry; Metallurgy | 3 | Active |
| US7387751B2 | Method of preparing organomagnesium compounds | Chemistry; Metallurgy | 3 | Active |
| US7397983B2 | Light applicator and method for producing a diffuser | Human Necessities | 3 | Expired |
| US8934507B2 | Wavelength-tunable light source | Electricity | 3 | Active |
| US7400724B2 | Device and method for use in quantum crytography | Electricity | 3 | Expired |
| US9296664B2 | Energetic active composition comprising a dihydroxylammonium salt or diammonium salt of a bistetrazolediol | Chemistry; Metallurgy | 3 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.